Longs

Feb 4, 2026

•

19 min read

Special Situation: All Eyes on ABVX

Why we think this biotech trade, while popular, has limited downside risk in the event no suitor comes to scoop them up.

Paul Cerro

Longs

Fear-Based Investing - Part 2 // Future of Weapons Screening

Jan 5, 2026

•

34 min read

Fear-Based Investing - Part 2 // Future of Weapons Screening

Why a more dangerous everyday environment is allowing this stock to take advantage

Paul Cerro

Longs

Dec 9, 2025

•

21 min read

Fear-Based Investing - Part 1 // +226%

An update on Owlet (OWLT) after a ~226% run-up

Paul Cerro

Bankruptcy

Dec 2, 2025

•

5 min read

🎙️ IC #7: A Phoenix Rising From the Ashes - Talking Weight Watchers (WW) Post-Bankruptcy

An open discussion with David Helderman, Director of Investor Relations at WW International (WW)

Paul Cerro

Longs

Bunch of Quick Earnings Updates - Part II: (REAL, KITS, SNWV, LNSR)

Nov 13, 2025

•

25 min read

Bunch of Quick Earnings Updates - Part II: (REAL, KITS, SNWV, LNSR)

Going over earnings and our thoughts given updated information

Paul Cerro

Longs

Quick Update: SNWV's Recent Pre-Announcement

Oct 7, 2025

•

11 min read

Quick Update: SNWV's Recent Pre-Announcement

Rehashing the math after lowering FY'25 guide

Paul Cerro

Longs

🎙️ IC #6: Talking Sanuwave Health (SNWV) w/Tenva Capital

Oct 2, 2025

•

4 min read

🎙️ IC #6: Talking Sanuwave Health (SNWV) w/Tenva Capital

An open discussion on the opportunity with SNWV

Paul Cerro

Longs

SNWV: A Med Devices Co. In Its Early Innings

Sep 22, 2025

•

6 min read

SNWV: A Med Devices Co. In Its Early Innings

Why we're bullish on Sanuwave Health, and why a post-Q2 earnings pullback makes for a compelling opportunity to potentially >2x

Paul Cerro

Longs

Why We're Excited About These New Situations: LNSR, PRPL, and LE

Sep 8, 2025

•

23 min read

Why We're Excited About These New Situations: LNSR, PRPL, and LE

An update on DKS/FL, LNSR and new ideas for PRPL and LE

Paul Cerro

Bankruptcy

Aug 25, 2025

•

22 min read

Special Situation: Betting on WW Post-Bankruptcy

Why a slimmed down version of Weight Watchers might be poised to take on the next stage of weight loss

Paul Cerro

Longs

Aug 11, 2025

•

22 min read

A Double Hiding North of the Border

Why we're excited about a small(ish) company in Maple Leaf country

Paul Cerro

Longs

When Misunderstandings Create Opportunities

Jul 23, 2025

•

18 min read

When Misunderstandings Create Opportunities

Why we decided to buy OneSpaWorld (OSW) with just a few hours of research

Paul Cerro

Longs

Jun 5, 2025

•

21 min read

A Bunch of Quick Position Updates

SHCO, LNSR, LQDA, CPRI, GENK, DKS, and HIMS

Paul Cerro

Longs

REAL: Q1'25 Earnings Shows Oversold +35% Reversal in 3 Weeks

May 14, 2025

•

14 min read

REAL: Q1'25 Earnings Shows Oversold +35% Reversal in 3 Weeks

Why the recent earnings selloff leaves us confused, but unfazed.

Paul Cerro

Longs

REAL: A Misunderstood Tariff Beneficiary Hiding in Plain Sight

Apr 17, 2025

•

26 min read

REAL: A Misunderstood Tariff Beneficiary Hiding in Plain Sight

Why we've decided to look at this opportunity after an >50% drawdown from recent highs

Paul Cerro

Longs

Open Letter: Lensar (LNSR) Shareholders Should Reject Alcon's (ALC) Takeover Offer

Mar 24, 2025

•

5 min read

Open Letter: Lensar (LNSR) Shareholders Should Reject Alcon's (ALC) Takeover Offer

ALC is getting a sweetheart deal and grossly undervalues LNSR

Paul Cerro

Longs

Updates: CPRI Divestment & BBW Earnings Opportunity + HIMS Trade Idea

Mar 19, 2025

•

18 min read

Updates: CPRI Divestment & BBW Earnings Opportunity + HIMS Trade Idea

Taking a look at the CPRI trade w/ new info and why BBW is looking good after that earnings print

Paul Cerro

Longs

LNSR: LENSAR Upside Into Global Clearance Looks Compelling

Feb 24, 2025

•

26 min read

LNSR: LENSAR Upside Into Global Clearance Looks Compelling

Growing procedural market share, inflecting positive FCF, and a growing recurring revenue segment

Paul Cerro

Longs

Jan 21, 2025

•

24 min read

A Few Updates and Two Pitches

Going over SHCO, LQDA, Capri (CPRI), Tile Shop (TSSH), and the FDA.

Paul Cerro

Longs

Yutrepia's Launch: A Catalyst for Liquidia (LQDA)

Jan 7, 2025

•

19 min read

Yutrepia's Launch: A Catalyst for Liquidia (LQDA)

Why we think the path to a 2x for LQDA is likely

Paul Cerro

Longs

Daktronics (DAKT) Potential to $40/Share

Dec 8, 2024

•

23 min read

Daktronics (DAKT) Potential to $40/Share

A follow-up to our original note on why we're bullish on DAKT

Paul Cerro

Longs

Two New 'Special Situation' Positions + Sizing Up A Long And Closing Contracts

Nov 17, 2024

•

12 min read

Two New 'Special Situation' Positions + Sizing Up A Long And Closing Contracts

Portfolio Update #8

Paul Cerro

Longs

BBW: After An >150% Return, Build-A-Bear Still Looks Close to a Double

Nov 13, 2024

•

16 min read

BBW: After An >150% Return, Build-A-Bear Still Looks Close to a Double

Why investors are sleeping on, and not with, this teddy bear name

Paul Cerro

Longs

HIMS: Post Q3 Earnings Breakdown + Issues That Marketing Is Telling Us

Nov 5, 2024

•

4 min read

HIMS: Post Q3 Earnings Breakdown + Issues That Marketing Is Telling Us

A stellar quarter and a solid beat shows how high HIMS can fly

Paul Cerro

Longs

HIMS: Analyzing the New Weight Loss Paper + Updated Model and PT

Oct 30, 2024

•

4 min read

HIMS: Analyzing the New Weight Loss Paper + Updated Model and PT

Encouraging patient outcomes from HIMS compounded GLP-1 offerings

Paul Cerro

Longs

Special Situation: All Eyes on ABVX

Fear-Based Investing - Part 2 // Future of Weapons Screening

Fear-Based Investing - Part 1 // +226%

🎙️ IC #7: A Phoenix Rising From the Ashes - Talking Weight Watchers (WW) Post-Bankruptcy

Bunch of Quick Earnings Updates - Part II: (REAL, KITS, SNWV, LNSR)

Quick Update: SNWV's Recent Pre-Announcement

🎙️ IC #6: Talking Sanuwave Health (SNWV) w/Tenva Capital

SNWV: A Med Devices Co. In Its Early Innings

Why We're Excited About These New Situations: LNSR, PRPL, and LE

Special Situation: Betting on WW Post-Bankruptcy

A Double Hiding North of the Border

When Misunderstandings Create Opportunities

A Bunch of Quick Position Updates

REAL: Q1'25 Earnings Shows Oversold +35% Reversal in 3 Weeks

REAL: A Misunderstood Tariff Beneficiary Hiding in Plain Sight

Open Letter: Lensar (LNSR) Shareholders Should Reject Alcon's (ALC) Takeover Offer

Updates: CPRI Divestment & BBW Earnings Opportunity + HIMS Trade Idea

LNSR: LENSAR Upside Into Global Clearance Looks Compelling

A Few Updates and Two Pitches

Yutrepia's Launch: A Catalyst for Liquidia (LQDA)

Daktronics (DAKT) Potential to $40/Share

Two New 'Special Situation' Positions + Sizing Up A Long And Closing Contracts

BBW: After An >150% Return, Build-A-Bear Still Looks Close to a Double

HIMS: Post Q3 Earnings Breakdown + Issues That Marketing Is Telling Us

HIMS: Analyzing the New Weight Loss Paper + Updated Model and PT

Cedar Grove Capital Management